These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
65 related items for PubMed ID: 7933610
1. [Development of new drugs for intractable vasculitis--lipo-PGE1 and monoclonal antibody]. Matsuda T, Hoshi K, Igarashi R, Ichikawa Y. Nihon Rinsho; 1994 Aug; 52(8):2187-91. PubMed ID: 7933610 [Abstract] [Full Text] [Related]
2. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy. Hoshi K, Mizushima Y, Kiyokawa S, Yanagawa A. Drugs Exp Clin Res; 1986 Aug; 12(8):681-5. PubMed ID: 3757764 [Abstract] [Full Text] [Related]
6. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats. Goto J, Araki H, Otomo S, Aihara H. Drugs Exp Clin Res; 1986 Aug; 12(11):917-21. PubMed ID: 3816509 [Abstract] [Full Text] [Related]
10. Interaction between non-ionic contrast medium and prostaglandin E1 incorporated in lipid microspheres: in-vitro comparative study of direct and non-direct mixing. Hayashi H, Uchiyama N, Kawamata H, Takagi R, Abe Y, Kumazaki T. Radiat Med; 2000 Aug; 18(4):219-25. PubMed ID: 11246996 [Abstract] [Full Text] [Related]
11. The effect of prostaglandin E1 incorporated in lipid microspheres on thrombus formation and thrombus disaggregation and its potential to target to the site of vascular lesions. Sim AK, McCraw AP, Cleland ME, Aihara H, Otomo S, Hosoda K. Arzneimittelforschung; 1986 Aug; 36(8):1206-9. PubMed ID: 3778557 [Abstract] [Full Text] [Related]
13. Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere. Luo Y, Fan Q, Yu Y, Zhang L, Dong L, Luo H. Sci Rep; 2022 Sep 13; 12(1):15363. PubMed ID: 36100635 [Abstract] [Full Text] [Related]
16. New aspect of anti-inflammatory action of lipo-prostaglandinE1 in the management of collagen diseases-related skin ulcer. Murota H, Kotobuki Y, Umegaki N, Tani M, Katayama I. Rheumatol Int; 2008 Sep 13; 28(11):1127-35. PubMed ID: 18461292 [Abstract] [Full Text] [Related]
17. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Lovric S, Erdbruegger U, Kümpers P, Woywodt A, Koenecke C, Wedemeyer H, Haller H, Haubitz M. Nephrol Dial Transplant; 2009 Jan 13; 24(1):179-85. PubMed ID: 18685144 [Abstract] [Full Text] [Related]
18. Clinical study of Lipo PGE1-inhibiting platelet activation in acute rejection after kidney transplantation. Zhang Y, Guan DL, Xia CQ, Han ZY, Xu JJ, Gao JZ, Wu KR. Transplant Proc; 2005 Dec 13; 37(10):4208-10. PubMed ID: 16387079 [Abstract] [Full Text] [Related]
20. Effects of PGE1 on the development of diabetes and surface markers of lymphocytes in BB/W/Tky rats. Suzuki M, Negishi K, Itabashi A, Katayama S, Ishii J, Komeda K, Kawazu S. Diabetes Res; 1991 Oct 13; 18(2):95-9. PubMed ID: 1841818 [Abstract] [Full Text] [Related] Page: [Next] [New Search]